Search…

Sugon: The company has not carried out research and development, production, and operations related to lithography machines.

20/04/2026

On April 20th, Inspur stated on their interactive platform that the company has not carried out research and development, production, or business operations related to photolithography machines.

Latest

3 m ago

China Automobile Association: From January to March 2026, the top ten companies in terms of automobile sales sold a total of 5.94 million vehicles.

3 m ago

Guosheng Securities: Net profit in the first quarter was 1.4687 million yuan, a year-on-year decrease of 97.91%

4 m ago

Novartis: Etavopivat achieved two co-primary endpoints in the Phase III HIBISCUS trial for sickle cell disease. In the Phase III trial, etavopivat reduced vaso-occlusive crisis events by 27%. Regulatory approval submission for etavopivat is planned for the second half of 2026.

4 m ago

Fenglong Stock: The deadline for the tender offer has expired and the stock will be suspended from trading starting from April 21st.

4 m ago

Novo Nordisk (NVO.N): Etavopivat achieved two co-primary endpoints in the Phase III HIBISCUS trial for sickle cell disease. In the Phase III trial, etavopivat reduced vascular occlusion crisis events by 27%. Regulatory approval application for etavopivat is planned to be submitted for the first time in the second half of 2026.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services